top of page
Regenerative Gene Therapy of Tomorrow
First in class RNAi combination therapy that overcomes the barriers of cell cycle re-entry
THERAPY
Myocardial infarction / Heart failure
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. more...
PRESS
WHY CHOOSE CARDIOGEN
Innovation and Excellence in Cardiovascular Regeneration
Cardiogen is committed to redefining cardiovascular care through innovative approaches and unparalleled excellence. Our focus on pioneering research and developing a new sets us apart as leaders in the field of cardiovascular regeneration.
bottom of page